Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

9.23
-0.5100-5.24%
Post-market: 9.270.0420+0.46%19:34 EDT
Volume:477.04K
Turnover:4.48M
Market Cap:158.30M
PE:-0.74
High:9.69
Open:9.65
Low:9.19
Close:9.74
52wk High:25.50
52wk Low:9.19
Shares:17.15M
Float Shares:14.99M
Volume Ratio:1.16
T/O Rate:3.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.71
PE(LYR):-0.63

Loading ...

Tonix Pharmaceuticals Q1 EPS USD -2.93

THOMSON REUTERS
·
May 12

Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights

GlobeNewswire
·
May 12

Alliance Global Partners Keeps Their Buy Rating on Tonix Pharma (TNXP)

TIPRANKS
·
May 11

EXE, IP, ESPR, CMPS, TNXP Trending With Analysts

TIPRANKS
·
May 09

Tonix Pharmaceuticals Holding Corp expected to post a loss of $2.43 a share - Earnings Preview

Reuters
·
May 08

Tonix Pharmaceuticals shareholders approve 2026 stock incentive plan at annual meeting

Reuters
·
May 08

Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients

GlobeNewswire
·
May 06

Tonix publishes TNX-4800 Lyme disease prevention presentation

Reuters
·
May 06

Tonix Pharma (TNXP) Receives a Buy from Alliance Global Partners

TIPRANKS
·
May 04

Tonix Pharmaceuticals initiated with a Buy at TD Cowen

TIPRANKS
·
May 04

Tonix Q1 net loss widens to $40.8 million; net revenue rises to $6.9 million

Reuters
·
May 02

Tonix plans adaptive Phase 2 field trial of TNX-4800 for Lyme prevention

Reuters
·
Apr 29

Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire
·
Apr 23

Tonix publishes Day 20 steady-state PK study of TONMYA in clinical journal

Reuters
·
Apr 15

Tonix publishes investor deck highlighting TONMYA fibromyalgia launch, reports USD 208 million cash

Reuters
·
Apr 08

Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA), Nuvalent (NUVL) and Tonix Pharma (TNXP)

TIPRANKS
·
Apr 06

Tonix CEO Seth Lederman buys TNXP shares worth $0.1 million

Reuters
·
Apr 01

Tonix publishes investor presentation highlighting TONMYA fibromyalgia drug launch progress

Reuters
·
Apr 01

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

GlobeNewswire
·
Mar 31

Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?

Benzinga
·
Mar 30